Functional dyspepsia (FD) is a common disorder in East and Southeast Asia where subjects experience post prandial fullness/bloating, early satiety, belching, epigastric pain, and/or burning. A subset of patients with FD experience triggers exclusively related to meals, defined as the post prandial distress syndrome in the Rome IV guidelines. There is significant overlap of symptoms and implicated pathogenic factors with another common functional gastrointestinal disorder, irritable bowel syndrome (IBS) and in fact, a significant proportion of subjects have FD/IBS overlap. The introduction of the low-FODMAP diet has changed the paradigm of treatment for IBS. Like IBS, dietary management appears to be important to patients with FD and clinicians treating the condition. This review aims to examine the current role of diet in the management of FD in East and Southeast Asia, with an exploration of the likely efficacy and mechanisms of action of the low-FODMAP diet in this region.
Introduction
Functional gastrointestinal disorders (FGID) are common and are characterized by the absence of overt structural or metabolic abnormalities to explain chronic abdominal symptoms. 1 Functional dyspepsia (FD) and irritable bowel syndrome (IBS) are two of the most common FGID. In East and Sinophone Southeast Asia, a region that includes China, Hong Kong, Taiwan, Korea, and Japan, FD is as prevalent as seen in the West, while IBS rates are lower. [2] [3] [4] [5] [6] [7] Currently, the gold standard for the diagnosis of FD is the Rome IV criteria. 1 Rome IV subdivides FD into two sub groups, dependent on whether the symptoms are meal-related, the post prandial distress syndrome, or not, the epigastric pan syndrome. Currently, there are no reliable biomarkers to aid in the diagnosis of FD. 1 The difficulty with clinicians involved in the management of FD is that the diagnosis is symptom-based, and many of the symptoms overlap with other conditions, leading to diagnostic confusion.
Appropriate diagnosis of FD enables rational treatment for patients and results in considerable societal benefits in terms of preservation of healthcare resources. Unfortunately, current treatments for FD only demonstrate modest effectiveness over placebo, and not all treatments are effective in all cases of FD. Currently, management of FD does not include dietary manipulation even though a large proportion of patients believe their symptoms to be triggered by food intake. IBS, a similar related FGID, also historically had a large proportion of subjects who believed that food triggered their symptoms. The introduction of the low-FODMAP diet has been embraced by clinicians and patients alike after rigorous clinical trials demonstrated efficacy rates of around 70% for relief of pain and bloating in IBS. 8, 9 The low-FODMAP diet is now mainstream and adopted into the treatment algorithm of IBS. This review aims to examine the evidence for the role of diet, in particular the low-FODMAP diet, in the management of FD in East Asians. This will be accomplished through a review of epidemiological studies in East Asia where diet was noted to be a trigger for FD symptoms, an examination of the pathophysiological mechanisms underlying FD particularly focused on East Asians and how the low-FODMAP addresses these mechanisms.
and their FD symptoms. 14, 15 A study by Miura and colleagues, which surveyed the practices of clinicians involved in the treatment of FD in the Asia-Pacific region, found that between 79% and 95% dispensed lifestyle or dietary advice in the treatment of FD and IBS. 14 However, in what form the dietary advice was dispensed is unclear, and it appears dietitians are not routinely involved in the dietary management of FD patients in East Asia. Published and anecdotal data suggest the dietary advice includes eating frequent smaller meals, reduction/avoidance of fat, chili, alcohol, carbonated drinks and caffeine in the diet, and avoidance of ambiguous "irritating" foods. 16, 17 In fact, the treatment algorithm for FD in Asia does not include dietary advice or manipulation despite its apparent widespread application. 16, 18 it near impossible to compare between the studies. Dietary factors examined include the regularity of the meals, the addition of snacking between meals, the speed at which a meal was consumed, the numbers of serves of vegetables/fruit (objective), and the ingestion of junk food/windy food were amongst the factors assessed. Despite this, it is clear that patients and clinicians alike acknowledge the association between diet and FD symptoms, but there appears to be no structured way to examine this association in epidemiological studies.
In terms of foods cited to aggravate or relieve FD symptoms, Table 2 examines studies in the East and Southeast Asia region. Ingested items positively associated with an increase in FGID symptoms include milk intake, a high-salt diet, and a high-fat diet. Intriguingly, the study by Min and colleagues found no association with dairy foods and FD, despite the fact that hydrogen breath tests utilizing lactose, found that even moderate doses of lactose triggered FGID symptoms in subject with FGID. 23, 35 Only two ingested food items were associated with an improvement in FGID-tea, which appears to act by antagonizing adenosine receptors, and kiwifruit, which may acts as a bulking agent and through the activation of colonic motility receptors. [28] [29] [30] Ginger appears to affect gastric motility but appears to have no impact on gastrointestinal symptoms in the study by Hu and colleagues. 25 Again, it appears that the association between food and the amelioration/exacerbation of gastrointestinal symptoms is recognized by clinicians and researchers, but the precise mechanisms and the specific foods that drive the association is at present unclear. Unfortunately, no studies have been performed on the effect of rice on the symptoms of FGID in East and Southeast Asia, despite the fact that it is the dominant grain associated with traditional diets in the region. Levitt and colleagues demonstrated that rice is completely absorbed from the intestine and generates very little intestinal gas after ingestion as evaluated by hydrogen breath tests. 33 FODMAP analysis of rice indicates that it is low 
Functional dyspepsia in East and Southeast Asia
Functional gastrointestinal disorders in East and Southeast Asia appear to have a different phenotype than that defined in the Rome IV consensus, which has been developed based on studies performed ostensibly in Caucasian subjects. Drivers of these differences in the presentation of FD and IBS in East Asia include language, cultural beliefs/societal factors, pain experience, differences in the microbiota, and different rates of FD/IBS overlap. 34 In terms of language, there is no question that the need to translate the ROME IV instrument into the various languages in the East and Southeast Asian region impacts on the ability of researchers in FGID to be able to be confident that the pain and discomfort described in one language is equivalent to that described by another language. For example, in the Chinese language, there is only one character for the words bloating and distension, while in English, the two symptoms have very different meanings, features, and pathophysiology. 37, 38 Furthermore, there was much diagnostic confusion amongst Chinese patients about the translation for early satiety and post prandial bloating in an important randomized, controlled trial performed in Hong Kong (personal communications). 39 These linguistic differences between countries and nuances in the language can undoubtedly have an impact on the "phenotype" of FD patients in this region.
In East Asia, cultural beliefs and societal factors impact greatly on the expression of symptoms and healthcare-seeking behavior. Cultural beliefs related to healing-provoking or illness-provoking qualities of food are manifest in the pervasive concepts of the "cold" and "heaty" essence of food. [10] [11] [12] [13] Frequently, East and Southeast Asians will attempt to restore balance in their health by brewing tonics and soups including items such as dried ginseng, lily bulbs, and black fungus. Patients may delay their presentation to a clinician (frequently referred to as a Western Medicine Practitioner as opposed to a Chinese Medicine Practitioner) in an attempt to selfheal. [10] [11] [12] [13] In terms of societal factors, there is a strong cultural bias in East Asia against the suggestion of mental disorders, and unfortunately, most patients in this region tend to be resistant to a diagnosis of a FGID. In the study by Tan and colleagues, the utilization of an antidepressant to treat FD resulted in large dropouts in part related to the cultural bias against a functional disorder. 40 Moreover, the high rates of cholecystectomies in IBS subjects and the preoccupation with organic pathology in FD is in part due to this cultural bias. 41 Finally, a proportion of IBS subjects may be misdiagnosed as FD due to the fact that Asians tend not to readily volunteer their bowel habit. 41, 42 In a study by Gwee and colleagues, 77% of IBS subjects who initially report normal stool frequency were found on detailed questioning to have either constipation, diarrhea, or both. 42 These patients would likely be diagnosed as FD in the absence of the detailed bowel habit abnormality and may account in part for the comparatively low prevalence rate of IBS when compared to Western data.
Studies performed ostensibly on Caucasian FGID subjects have led to the Rome Consensus differentiating patients with FGID on the basis of the location of their abdominal pain. According to the latest iteration of the ROME Consensus statement, FD subjects must have epigastric pain or burning, where epigastric refers to an area between the xiphisternum and the umbilicus. Alternately, subjects with IBS have abdominal pain, which is defined as pain in the umbilicus, flank regions, suprapubic regions, and iliac fossa regions. 1, 43, 44 Numerous studies have indicated that IBS in Asian subjects tends to have more upper abdominal/epigastric pain and discomfort. 45, 46 In a study by Gwee and colleagues, 52% of Indian subjects with IBS experienced their symptoms in the epigastric and umbilical region, compared with only 4% of English subjects. 45 This early finding has been supported by a more recent study by Xiong and colleagues who found that southern Chinese subjects with abdominal pain related to IBS was located mainly in the epigastrium or the right upper quadrant. This is another factor that could partially account for the relative prevalence of FD when compared with IBS in this region. 46 Although our understanding in this area is in its infancy, the gut microbiota is different between Asians and Caucasians. Several lines of evidence currently support this, and further evidence is likely forthcoming with the increasing sophistication of microbiota profiling. Helicobacter pylori prevalence rates are vastly different between these different ethnic groups. 47 Furthermore, gut metagenomic analyses demonstrate an abundance of porphyranases and agarases in the Japanese population, while these are notably absent from the North American gut microbiota. 48 Finally, in the study by Tan and colleagues, breath test results from Chinese FD subjects revealed 100% were producers of methane, compared with 10-32.3% in Indian and Caucasian subjects. 49, 50 Functional dyspepsia and IBS frequently overlap. In East and Southeast Asia, the odds of having FD in an IBS patient is almost two to four times that of control subjects. 3, 51 In China, several studies found FD and IBS overlap of between 21% and 32% in subjects who had either FGID disorder. In Japan, the rate of FD and IBS overlap varied significantly from 10% to 56%. 52, 53 In Korea, the overlap rate was found to be 27%. 3 The high rate of FD and IBS overlap in East and Southeast Asia is in general similar to rates in Western countries. Drivers of FD and IBS overlap are unknown.
In summary, the presentation of FD and IBS in East and Southeast Asians appears to be modulated by a number of factors that are specific to the region. Importantly, clinicians managing FD in this region need to be sensitive to these factors, which may account for the "atypical" phenotype of FD observed here. In particular, attention should be paid to the misdiagnosis of IBS as FD and the health beliefs that may delay or modulate health seeking behavior in FD subjects.
The low-FODMAP diet in functional dyspepsia in East Asia
FODMAPs is an acronym that refer to a collection of fermentable short chain carbohydrates that are either indigestible because of the absence of appropriate hydrolases or only slowly absorbed in the small intestine. 8 They are ubiquitous in the Western diet but little is known about the presence of FODMAPs in other diets. Recently, a review examined the applicability of the low-FODMAP diet in the East and Southeast Asian diet. 36 This review found that based on the foods that have been analyzed for FODMAP content to date, there were many examples of high-FODMAP foods that were commonly consumed in East and Southeast Asia. In fact, high-FODMAP ingredients were frequently found in what would be considered to be the national dishes of many countries in the region including dumplings/sweet red bean soup in China and Hong Kong, kimchi in Korea, stinky tofu in Taiwan, and ramen/udon noodles in Japan. In this region, oligosaccharides such as fructo-oligosaccharides are found in garlic, onion and wheat, and galacto-oligosaccharides found in green beans, red beans, and soy beans; the disaccharide, lactose, was commonly found in milk drinks, sweet milk breads, and condensed milk; the monosaccharide, fructose, was found in apples and mangoes; and polyols were found in lychees and mushrooms. This review demonstrated that the low-FODMAP diet was likely to similarly applicable to IBS subjects in the East and Southeast Asian regions as in Western regions.
The premise underlying the low-FODMAP diet in IBS is simple. FODMAPs are a collection of fermentable short chain carbohydrates commonly found in a wide range of foods. Malabsorption of these carbohydrates occurs in all subjects and leads to distal ileum/colonic fermentation. This generates gas and an osmotic load, with the net effect being luminal distension. 9 For most subjects, this either does not cause any symptoms or only minor symptoms of flatulence, bloating, and discomfort. However in subjects with IBS, ingestion of a quantity of FODMAPs that overwhelms the visceral sensitivity threshold generates symptoms including pain, bloating, and flatulence through stimulation of mechanoreceptors and possibly chemoreceptors. 9, 36 The low-FODMAP diet has recently been incorporated into the paradigm for the treatment of IBS, with restriction of high-FODMAP food resulting in a significant reductions of pain, bloating, flatulence, and an improvement in stool form/frequency. 8, 9 However, the low-FODMAP diet should not be adopted in subjects without IBS as there are impacts on the colonic microbiota, the long-term effects of which are unclear. Involvement of a dietitian would aide long-term liberalization of the diet and minimize nutritional compromise and possible microbiota alterations. 54 Current pathophysiological mechanisms implicated in the pathogenesis of FD include altered motility especially impaired accommodation and gastric emptying, visceral hypersensitivity, low-grade mucosal inflammation, dysbiosis of the gut microbiota, and abnormal central pain processing. 16 There appears to be a degree of overlap with the mechanisms that are implicated in the pathogenesis of IBS. Furthermore, subjects with FD also have prominent "gas" related symptoms including bloating, belching, and distension. Subjects with FD also experience epigastric/abdominal pain and discomfort, and, in the prandial distress syndrome sub-group, these symptoms are exclusively mealrelated. This has led to researchers involved in FGID research to question whether FD and IBS are in fact two separate but related diseases, or simply one disease process with varying phenotypes.
As discussed in the preceding texts, a subset of subjects with IBS in East and Southeast Asia are likely to misclassified as FD. Furthermore, a significant proportion of subjects with FD will have IBS overlap. It is clear that, in these subjects, a low-FODMAP diet might be an appropriate management strategy as part of a multidisciplinary approach to FD. However, currently there is no high-quality evidence to suggest that a low-FODMAP diet would be of benefit in patients with FD. A reduction in luminal gas, osmotic load, luminal water content will result in a reduction of mechanoreceptor stimulation, while a reduction in the generation of short chain fatty acids is likely to alter chemoreceptor stimulation as well as have a number of as yet poorly understood systemic immunomodulatory and epigenetic effects. Furthermore, there is complex interaction across the entire intestinal system. Examples of this include the gastrocolic reflex, which occurs after the ingestion of a meal, demonstrating that processes occurring in the upper gastrointestinal tract trigger processes/pain in the lower gastrointestinal tract. The fact that gas infusion into the duodenum has been shown to produce more severe pain in IBS patients than in healthy controls, without affecting motility indices, supports this. 55, 56 Also, it has been shown that IBS patients demonstrate a prolonged and exaggerated gastrocolic response compared with that in control subjects. The fat component of the food appears to be the main stimulus for this response. 56, 57 By the same token, there is also evidence to suggest that processes affecting the lower gastrointestinal tract have the capacity to generate upper gastrointestinal symptoms. In particular, cologastric reflexes appear to be important in FD. In a study performed in a paediatric population with FD and a high rate of comorbid functional constipation, the rate of the delayed gastric emptying was improved when laxatives were utilized to treat the constipation. 58 A well-designed randomized controlled trial examining the benefit of a low-FODMAP diet in subjects with FD, and the mechanisms driving this response is warranted.
Conclusion
Patients and clinicians alike in East Asia recognize the strong association between diet and FD with multiple population-based studies attempting to clarify this association. Furthermore, clinicians appear to be dispensing dietary advice, but unfortunately, the dietary advice dispensed by clinicians to patients with FD is of uncertain content, is unstructured, not evidence-based, and almost certainly does not involve a dietitian. Published reviews in the role of diet in FGID indicate that dietary advice dispensed by clinicians include eating frequent smaller meals, reduction/avoidance of fat, chili, alcohol, carbonated drinks, and caffeine in the diet, and avoidance of ambiguous "irritating" foods. The low-FODMAP diet has been adopted as first line treatment for IBS in many centers internationally. Despite the similarities in phenotypes and proposed pathogenic mechanisms between FD and IBS, there is currently no evidence for the low-FODMAP diet in FD. Currently, in East Asians, there is evidence for the low FODMAP in subjects with FD/IBS overlap or in subjects with FD who on detailed questioning are found to have been misclassified as FD when in fact the subject has IBS. A dietitian should be involved in the implementation and longer term management of the low-FODMAP diet in this region. High-quality studies to determine the efficacy of the low-FODMAP diet are awaited.
